![Arun Swaminathan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arun Swaminathan
Vorstandsvorsitzender bei
COYA THERAPEUTICS, INC.
Vermögen: 45 600 $ am 31.08.2026
Profil
Dr. Arun Swaminathan is a Chief Executive Officer & Director at Coya Therapeutics, Inc. He is on the Board of Directors at Coya Therapeutics, Inc. Dr. Swaminathan was previously employed as a Chief Business Officer by Actinium Pharmaceuticals, Inc., a Chief Business Officer & Senior Vice President by Alteogen, Inc., a Chief Executive Officer by Lynkogen, Inc., a Director-Worldwide Brand by Bristol Myers Squibb Co., and a Head-Marketing by Labcorp Drug Development, Inc. He received his undergraduate degree from the University of Madras and a doctorate degree from the University of Pittsburgh.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2026 | 10’000 ( 0.04% ) | 45 600 $ | 31.08.2026 |
Aktive Positionen von Arun Swaminathan
| Unternehmen | Position | Beginn |
|---|---|---|
| COYA THERAPEUTICS, INC. | Vorstandsvorsitzender | 01.11.2024 |
Ehemalige bekannte Positionen von Arun Swaminathan
| Unternehmen | Position | Ende |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.03.2023 |
| ALTEOGEN INC. | Corporate Officer/Principal | 01.09.2021 |
Lynkogen, Inc. | Vorstandsvorsitzender | 01.03.2020 |
| COVANCE INC. | Vertrieb & Marketing | - |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Ausbildung von Arun Swaminathan
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
30
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Labcorp Drug Development, Inc.
 Labcorp Drug Development, Inc. Medical/Nursing ServicesHealth Services Provides medical laboratory testing and drug development services | Health Services |
University of Pittsburgh
 University of Pittsburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Madras
 University of Madras Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
Alteogen, Inc.
 Alteogen, Inc. BiotechnologyHealth Technology Engages in the research and development of biopharmaceuticals | Health Technology |
Coya Therapeutics, Inc.
 Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Lynkogen, Inc. |
